Avidicure
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$50M
Company Overview
Avidicure is a biotechnology company that develops a dual agonistic, multifunctional antibody modality designed to engage immune cells for targeted cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avidicure Comps
Public and private peers based on sector, stage, and business model.
Avidicure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 |
Key People
Founding team and executive leadership
Avidicure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| EQT Life Sciences | Seed |
| V-Bio Ventures | Seed |
| BioGeneration Ventures | Seed |
| Kurma Partners | Seed |
| Curie Capital | Seed |
Avidicure Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avidicure's valuation, stock price, and market status.
